Competing Bidder For GNC Argues Expected Sale To Chinese Firm Would Cause Security Risks In US
DynamicVetnures also contends Harbin Pharmaceutical is attempting to avoid a regulatory review by federal agencies on national security and other questions that is required when foreign companies make large investments in US businesses.
